— Know what they know.
Not Investment Advice

NOUV OTC

Nouveau Life Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +100.0% 1Y: +9900.0% 3Y: -0.0% 5Y: -85.7%
$0.00
+0.00 (+0.00%)
 
OTC · Industrials · Agricultural - Commodities/Milling · Tech Score Neutral · Power 54 · $90000 mcap · 744M float · 0.075% daily turnover · Short 56% of daily vol

Balance Sheet Trends

Total Assets
$1M +4482.2% ▲
4Y CAGR: +471.5%
Total Liabilities
$1M +13.0% ▲
4Y CAGR: +6.1%
Shareholders Equity
$316K +136.4% ▲
Cash & Investments
$4K +12.2% ▲
4Y CAGR: +33.5%
Total Debt
$68K +43.2% ▲
4Y CAGR: -27.0%
Net Debt
$64K +45.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2003FY2004FY2005FY2006FY2007
— Assets —
Cash$1K$8K$946$4K$4K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$1K$8K$946$4K$4K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$1K$8K$946$29K$4K
Property, Plant & Equip.$0$0$0$0$821K
Goodwill & Intangibles$0$0$0$0$506K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$1M
Total Assets$1K$8K$946$29K$1M
— Liabilities —
Accounts Payable$50K$67K$63K$137K$137K
Short-Term Debt$238K$244K$297K$47K$57K
Deferred Revenue$12K$3K$47K$29K$30K
Other Current Liabilities$291K$327K$327K$536K$556K
Total Current Liabilities$577K$625K$738K$675K$781K
Long-Term Debt$0$0$0$0$10K
Other Non-Current Liab.$0$0$0$0$223K
Total Non-Current Liabilities$223K$223K$223K$223K$233K
Total Liabilities$800K$848K$961K$898K$1M
— Equity —
Common Stock$22K$23K$25K$26K$30K
Retained Earnings-$1M-$2M-$2M-$2M-$3M
Accumulated OCI$0$302K$360K$547K$676K
Total Stockholders Equity-$799K-$840K-$960K-$869K$316K
Total Liabilities & Equity$1K$8K$946$29K$1M
— Key Metrics —
Total Debt$238K$244K$297K$47K$68K
Net Debt$237K$237K$296K$44K$64K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms